| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1558 | 2018 |
| Angiotensin–neprilysin inhibition in acute decompensated heart failure EJ Velazquez, DA Morrow, AD DeVore, CI Duffy, AP Ambrosy, ... New England Journal of Medicine 380 (6), 539-548, 2019 | 1348 | 2019 |
| Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry SJ Greene, J Butler, NM Albert, AD DeVore, PP Sharma, CI Duffy, CL Hill, ... Journal of the American College of Cardiology 72 (4), 351-366, 2018 | 1173 | 2018 |
| Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes KS Shah, H Xu, RA Matsouaka, DL Bhatt, PA Heidenreich, AF Hernandez, ... Journal of the American College of Cardiology 70 (20), 2476-2486, 2017 | 1096 | 2017 |
| Association of the hospital readmissions reduction program implementation with readmission and mortality outcomes in heart failure A Gupta, LA Allen, DL Bhatt, M Cox, AD DeVore, PA Heidenreich, ... JAMA cardiology 3 (1), 44-53, 2018 | 464 | 2018 |
| Titration of medical therapy for heart failure with reduced ejection fraction SJ Greene, GC Fonarow, AD DeVore, PP Sharma, M Vaduganathan, ... Journal of the American College of Cardiology 73 (19), 2365-2383, 2019 | 457 | 2019 |
| Heart failure and atrial fibrillation, like fire and fury MA Carlisle, M Fudim, AD DeVore, JP Piccini JACC: Heart Failure 7 (6), 447-456, 2019 | 361 | 2019 |
| Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from Diuretic Optimization Strategy Evaluation in Acute Decompensated … A Lala, SE McNulty, RJ Mentz, SM Dunlay, JM Vader, OF AbouEzzeddine, ... Circulation: Heart Failure 8 (4), 741-748, 2015 | 341 | 2015 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 293 | 2019 |
| Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review K McHugh, AD DeVore, J Wu, RA Matsouaka, GC Fonarow, ... Journal of the American College of Cardiology 73 (5), 602-611, 2019 | 279 | 2019 |
| Trends in 30-day readmission rates for patients hospitalized with heart failure: findings from the get with the guidelines-heart failure registry KE Bergethon, C Ju, AD DeVore, NC Hardy, GC Fonarow, CW Yancy, ... Circulation: Heart Failure 9 (6), e002594, 2016 | 221 | 2016 |
| Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019 | 212 | 2019 |
| Clinical outcomes in patients with acute decompensated heart failure randomly assigned to sacubitril/valsartan or enalapril in the PIONEER-HF trial DA Morrow, EJ Velazquez, AD DeVore, AS Desai, CI Duffy, AP Ambrosy, ... Circulation 139 (19), 2285-2288, 2019 | 203 | 2019 |
| Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial AD DeVore, S McNulty, F Alenezi, M Ersboll, JM Vader, JK Oh, G Lin, ... European journal of heart failure 19 (7), 893-900, 2017 | 194 | 2017 |
| Trends in noncardiovascular comorbidities among patients hospitalized for heart failure: insights from the get with the guidelines–heart failure registry A Sharma, X Zhao, BG Hammill, AF Hernandez, GC Fonarow, GM Felker, ... Circulation: Heart Failure 11 (6), e004646, 2018 | 190 | 2018 |
| Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines–Heart Failure registry JB Echouffo-Tcheugui, H Xu, AD DeVore, PJ Schulte, J Butler, CW Yancy, ... American heart journal 182, 9-20, 2016 | 181 | 2016 |
| Initiation, continuation, or withdrawal of angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with … LG Gilstrap, GC Fonarow, AS Desai, L Liang, R Matsouaka, AD DeVore, ... Journal of the American Heart Association 6 (2), e004675, 2017 | 166 | 2017 |
| Transplantation outcomes with donor hearts after circulatory death JN Schroder, CB Patel, AD DeVore, BS Bryner, S Casalinova, A Shah, ... New England Journal of Medicine 388 (23), 2121-2131, 2023 | 159 | 2023 |
| Kidney function and outcomes in patients hospitalized with heart failure RB Patel, GC Fonarow, SJ Greene, S Zhang, B Alhanti, AD DeVore, ... Journal of the American College of Cardiology 78 (4), 330-343, 2021 | 159 | 2021 |
| Effect of treatment with sacubitril/valsartan in patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial DL Mann, MM Givertz, JM Vader, RC Starling, P Shah, SE McNulty, ... JAMA cardiology 7 (1), 17-25, 2022 | 154 | 2022 |